+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Association of CYP2D6 gene polymorphism and psychoactive drug therapy side effects

Association of CYP2D6 gene polymorphism and psychoactive drug therapy side effects

Clinical Chemistry & Laboratory Medicine 39(Special Suppl.): S50

(PDF emailed within 1 workday: $29.90)

Accession: 034450869

Download citation: RISBibTeXText

Related references

1846G>A polymorphism of CYP2D6 gene and extrapyramidal side effects during antipsychotic therapy among Russians and Tatars: a pilot study. Drug Metabolism and Personalized Therapy 31(4): 205-212, 2016

CYP2D6 genotyping in patients on psychoactive drug therapy. Clinical Chemistry and Laboratory Medicine 38(9): 921-927, 2000

The frequency of CYP2D6 3* and 2D6 4* alleles in patients on psychoactive drug therapy. Clinical Chemistry & Laboratory Medicine 37(SPEC SUPPL ): S154, 1999

CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects. Bulletin of Experimental Biology and Medicine 160(5): 687-690, 2017

CYP2D6 polymorphism and side effects in schizophrenia and schizoaffective psychosis. Periodicum Biologorum 103(4): 315-319, 2001

CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status. Drug Metabolism and Disposition: the Biological Fate of Chemicals 34(4): 563-569, 2006

Effect of CYP2D6 genetic polymorphism on side effects of amitriptyline and nortriptyline. Clinical Pharmacology & Therapeutics 63(2): 150, 1998

CYP2D6 and GST gene polymorphism in epilepsy patients developing adverse drug reactions and toxicity to the antiepileptic drug phenytoin. Neurology 60(5 Suppl. 1): A91, March 11, 2003

Impact of gene promoter polymorphism of the UGT1A1-gene on the occurrance of irinotecan-induced side effects and drug effiacy. Journal of Clinical Oncology 23(16_Suppl): 3570-3570, 2016

Pharmacogenetics and drug therapy in psychiatry--the role of the CYP2D6 polymorphism. Current Pharmaceutical Design 13(2): 241-250, 2007

Pharmacogenetics and Drug Therapy in Psychiatry - The Role of the Cyp2D6 Polymorphism. Current Pharmaceutical Design 13(2): 241-250, 2007

Diabetes therapy--conclusion. Sequel 3: therapeutic failures, counterindications of drug therapy, side-effects, therapy of diseases and special conditions, therapy of side-effects. Fortschritte der Medizin 93(27): 1253-1255, 1975

An allelic association study of the Hhal polymorphism in the CYP2D6 gene in Parkinsons disease. Neurology 46(2 SUPPL ): A377-A378, 1996

Drug extrapyramidal side effects. CYP2D6 genotypes and phenotypes. European Journal of Clinical Pharmacology 55(9): 659-665, 1999

Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels. Drug Metabolism and Pharmacokinetics 31(2): 156-162, 2016